Abstract:Although researchers have made great progress in the development of responsive polymeric materials for controlled drug release or diagnostics over the last 10 years, therapeutic results still lag behind expectations. The development of special materials that respond to physiological relevant concentrations, typically within the micromolar or nanomolar concentration regime, remains challenging. Therefore, researchers continue to pursue new biomaterials with unique properties and that respond to mild biochemical signals or biomarkers. Selenium is an essential element in human body with potential antioxidant properties. Because of selenium's electronegativity and atomic radius, selenium-containing compounds exhibit unique bond energy (C-Se bond 244 kJ mol⁻¹; Se-Se bond 172 kJ mol⁻¹). These values give the C-Se or Se-Se covalent bonds dynamic character and make them responsive to mild stimuli. Therefore, selenium-containing polymers can disassemble in response to changes under physiological relevant conditions. This property makes them a promising biomaterial for controlled release of drugs or synthetic enzyme mimics. Until recently, few researchers have looked at selenium-containing polymers as novel biomaterials. In this Account, we summarize our recent research on selenium-containing polymers and show their potential application as mild-responsive drug delivery vehicles and artificial enzymes. We begin by reviewing the current state of the art in the synthesis of selenium-containing main chain block copolymers. We highlight the dual redox and gamma-irradiation behaviors of diselenide-containing block copolymers assemblies, discussing the possibility of their use in a combination of chemotherapy and actinotherapy. We also describe the coordination of platinum with monoselenide containing block copolymers. Such structures offer the possibility of fabricating multidrug systems for cooperative chemotherapy. In addition, we summarize the methods for the covalent and noncovalent preparation of selenium-containing polymers with side chains, which highlight the opportunity to reversibly tune the amphiphilicity of selenium-containing polymers. Finally, we present strategies for the design of highly efficient selenium-containing dendritic polymers that can mimic enzymes. This field is still in its infancy period, and further research can only be limited by our imagination.

Preparation of Amphiphilic Diselenide Copolymer and Formation of Its Aggregates

Amphiphilic diselenide-containing supramolecular polymers

Side-chain selenium-containing amphiphilic block copolymers: Redox-controlled self-assembly and disassembly

Selenium-containing polymers: promising biomaterials for controlled release and enzyme mimics.

From Selenite To Diselenide-Containing Drug Delivery Systems

Diselenide-Bridged Doxorubicin Dimeric Prodrug: Synthesis and Redox-Triggered Drug Release

Enzymatic Synthesis of Selenium-Containing Amphiphilic Aliphatic Polycarbonate As an Oxidation-Responsive Drug Delivery Vehicle.

Selenol-Based Nucleophilic Reaction For The Preparation Of Reactive Oxygen Species-Responsive Amphiphilic Diblock Copolymers

Selenium-containing block copolymers and their oxidation-responsive aggregates

Diselenium-containing ultrathin polymer nanocapsules for highly efficient targeted drug delivery and combined anticancer effect

A Drug‐Free Therapeutic System for Cancer Therapy by Diselenide‐Based Polymers Themselves

Dual-Responsive Polyphosphoester-Doxorubicin Prodrug Containing a Diselenide Bond: Synthesis, Characterization, and Drug Delivery

Well-defined Labile Diselenide-Centered Poly(ε-Caprolactone)-based Micelles for Activated Intracellular Drug Release.

Design of Diselenide-Containing Polyprodrug and Its Ph/redox Co-Triggered Degradation and Slow Drug Release of for Tumor-Specific Chemotherapy

Enhanced bioreduction-responsive biodegradable diselenide-containing poly(ester urethane) nanocarriers

Redox-responsive Fluorescent Nanoparticles Based on Diselenide-containing AIEgens for Cell Imaging and Selective Cancer Therapy.

Preparation of Drug Carriers with Dual Redox-responsibility <i>via</i> Multicomponent Polymerization of Alkynes

Design of diselenide-containing polyprodrug and its pH/redox co-triggered degradation and slow drug release for tumor-specific chemotherapy

Supercritical Fluid-Assisted Fabrication Of Diselenide-Bridged Polymeric Composites For Improved Indocyanine Green-Guided Photodynamic Therapy

Diselenide-triggered Hydroxyethyl Starch Conjugate Nanoparticles with Cascade Drug Release Properties for Potentiating Chemo-Photodynamic Therapy.

ROS-Responsive Selenopolypeptide Micelles: Preparation, Characterization, and Controlled Drug Release